SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Auspex Pharmaceuticals, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Auspex Pharmaceuticals, Inc. ("Auspex” or "the Company") (Nasdaq: ASPX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Teva Pharmaceuticals Industries Ltd. (“Teva”).

Click here to learn more about the investigation http://brodsky-smith.com/910-aspx-auspex-pharmaceuticals-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Auspex shareholders will receive only $101.00 in cash for each share of Auspex stock they own. The investigation concerns whether the Board of Auspex breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Teva is underpaying for Auspex.

The transaction may undervalue Auspex which next year has its SD-809 drug scheduled for a commercial launch as a treatment for Huntington disease. However, SD-809 also is a potential treatment for tardive dyskinesia, which is a frequent side effect of anti-psychotic drugs. In addition, SD-809 is being studied as a potential treatment for Tourette’s syndrome. As a result, it has been estimated that SD-809 could have peak annual sales of $2 billion and an analyst has set a $105.00 per share price target for Auspex stock.

If you own shares of Auspex stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://brodsky-smith.com/910-aspx-auspex-pharmaceuticals-inc.html, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

Contacts:

Brodsky & Smith, LLC
Jason L. Brodsky, Esquire
Evan J. Smith, Esquire
877-LEGAL-90
http://brodsky-smith.com/910-aspx-auspex-pharmaceuticals-inc.html

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.